Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Observational Study of Safety and Effectiveness Following Administration of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
Brief Summary: This observational study will evaluate the safety and effectiveness following administration of adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine through both an ad hoc active monitoring system and a passive surveillance of hospitalization in a large cohort.


Options:
A: Arm Label: 6-23 months; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: 2-8 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: 9-17 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: 18-44 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: 45-60 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Arm Label: >60 years; Type: N/A; Interventions: Other: This is non-intervention observational study | Intervention Type: OTHER; Name: This is non-intervention observational study; Assigned to Arm(s): 18-44 years, 2-8 years, 45-60 years, 6-23 months, 9-17 years, >60 years
B: Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Biological: Influenza vaccine (FLU-v) | Arm Label: Group 3; Type: EXPERIMENTAL; Interventions: Biological: Influenza vaccine (FLU-v) | Arm Label: Group 4; Type: EXPERIMENTAL; Interventions: Biological: Influenza vaccine (FLU-v) | Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Biological: Influenza vaccine (FLU-v) | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: FLU-v Control | Intervention Type: BIOLOGICAL; Name: Influenza vaccine (FLU-v); Assigned to Arm(s): Group 1, Group 2, Group 3, Group 4 | Intervention Type: BIOLOGICAL; Name: FLU-v Control; Assigned to Arm(s): Control Group
C: Arm Label: 90 mcg of Influenza A/H7N7; Type: EXPERIMENTAL; Interventions: Biological: Influenza A/H7N7 Vaccine | Arm Label: 15 mcg of Influenza A/H7N7; Type: EXPERIMENTAL; Interventions: Biological: Influenza A/H7N7 Vaccine | Arm Label: 7.5 mcg of Influenza A/H7N7; Type: EXPERIMENTAL; Interventions: Biological: Influenza A/H7N7 Vaccine | Arm Label: 45 mcg of Influenza A/H7N7; Type: EXPERIMENTAL; Interventions: Biological: Influenza A/H7N7 Vaccine | Arm Label: Saline placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: Influenza A/H7N7 Vaccine; Assigned to Arm(s): 15 mcg of Influenza A/H7N7, 45 mcg of Influenza A/H7N7, 7.5 mcg of Influenza A/H7N7, 90 mcg of Influenza A/H7N7 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Saline placebo
D: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: ACTIVE_COMPARATOR; Interventions: Biological: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A